MSD’s HPV vaccine is now approved for prevention of anal cancer in Malaysia.
MERCK Sharp & Dohme’s (MSD) human papillomavirus (HPV) vaccine has now been approved for an extension of indication to include prevention of anal cancer in both males and females aged nine through 26 years. It is now the only vaccine indicated for prevention of cervical, vulvar and vaginal cancer in women; as well as genital warts and anal cancer prevention in both men and women.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
